Genetic rodent models of depression

Current Opinion in Pharmacology

Volumn 7, Issue 1, 2007, Pages 3-7

  El Yacoubi, Malika ^a   Vaugeois, Jean Marie ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIDEPRESSANT AGENT; BUSPIRONE; CITALOPRAM; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

A J MOUSE; ANIMAL BEHAVIOR; BAGG ALBINO MOUSE; C57BL MOUSE; DEPRESSION; DISEASE MODEL; ENVIRONMENTAL FACTOR; FORCED SWIMMING TEST; GENETICS; HEREDITY; LEARNED HELPLESSNESS; NONHUMAN; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; REVIEW; SPRAGUE DAWLEY RAT; SYMPTOMATOLOGY;

ANIMALS; DEPRESSION; DISEASE MODELS, ANIMAL; MICE; MODELS, GENETIC; RATS;

EID: 33846931611     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2006.11.002     Document Type: Review

References (56)

1. Sullivan P.F., Neale M.C., and Kendler K.S. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 157 (2000) 1552-1562
2. Hamet P., and Tremblay J. Genetics and genomics of depression. Metabolism 54 Suppl 1 (2005) 10-15
3. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
4. Redei E.E., Ahmadiyeh N., Baum A.E., Sasso D.A., Slone J.L., Solberg L.C., Will C.C., and Volenec A. Novel animal models of affective disorders. Semin Clin Neuropsychiatry 6 (2001) 43-67
5. Willner P., and Mitchell P.J. The validity of animal models of predisposition to depression. Behav Pharmacol 13 (2002) 169-188
6. Holmes P.V. Rodent models of depression: reexamining validity without anthropomorphic inference. Crit Rev Neurobiol 15 (2003) 143-174
7. O'Neil M.F., and Moore N.A. Animal models of depression: are there any?. Hum Psychopharmacol 18 (2003) 239-254
8. Cryan J.F., and Mombereau C. In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 9 (2004) 326-357
9. Mitchell P.J., and Redfern P.H. Animal models of depressive illness: the importance of chronic drug treatment. Curr Pharm Des 11 (2005) 171-203
10. Markou A. Editorial. Neurosci Biobehav Rev 29 (2005) 501. Markou edited a special issue of Neurosci Biobehav Rev devoted to 'Animal models of depression and antidepressant activity' that covers in 20 chapters the vast majority of animal models of depression existing in 2005.
11. Cryan J.F., and Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 4 (2005) 775-790
12. Dulawa S.C., and Hen R. Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neurosci Biobehav Rev 29 (2005) 771-783
13. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl) 134 (1997) 319-329
14. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
15. Porsolt R.D., Bertin A., and Jalfre M. Behavioural despair in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol 51 (1978) 291-294
16. Cryan J.F., Markou A., and Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23 (2002) 238-245
17. Cryan J.F., Valentino R.J., and Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29 (2005) 547-569
18. Cryan J.F., Page M.E., and Lucki I. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology (Berl) 182 (2005) 335-344
19. Steru L., Chermat R., Thierry B., Mico J.A., Lenegre A., Steru M., Simon P., and Porsolt R.D. The automated tail suspension test: a computerized device which differentiates psychotropic drugs. Prog Neuropsychopharmacol Biol Psychiatry 11 (1987) 659-671
20. Steru L., Chermat R., Thierry B., and Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85 (1985) 367-370
21. Cryan J.F., Mombereau C., and Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29 (2005) 571-625. The authors succeeded in rewiewing everything you always wanted to know about the TST but were afraid to ask!
22. Crowley J.J., and Lucki I. Opportunities to discover genes regulating depression and antidepressant response from rodent behavioral genetics. Curr Pharm Des 11 (2005) 157-169
23. Crowley J.J., Brodkin E.S., Blendy J.A., Berrettini W.H., and Lucki I. Pharmacogenomic evaluation of the antidepressant citalopram in the mouse tail suspension test. Neuropsychopharmacology 31 (2006) 2433-2442
24. Maier S.F., and Seligman M.E.P. Learned helplessness: theory and evidence. J Exp Psychol Gen 105 (1976) 3-46
25. Fleshner M., Nguyen K.T., Cotter C.S., Watkins L.R., and Maier S.F. Acute stressor exposure both suppresses acquired immunity and potentiates innate immunity. Am J Physiol 275 (1998) R870-R878
26. Sherman A.D., Sacquitne J.L., and Petty F. Specificity of the learned helplessness model of depression. Pharmacol Biochem Behav 16 (1982) 449-454
27. Maudhuit C., Prevot E., Dangoumau L., Martin P., Hamon M., and Adrien J. Antidepressant treatment in helpless rats: effect on the electrophysiological activity of raphe dorsalis serotonergic neurons. Psychopharmacology (Berl) 130 (1997) 269-275
28. Henn F.A., and Vollmayr B. Stress models of depression: forming genetically vulnerable strains. Neurosci Biobehav Rev 29 (2005) 799-804
29. Heurteaux C., Lucas G., Guy N., El Yacoubi M., Thummler S., Peng X.D., Noble F., Blondeau N., Widmann C., Borsotto M., et al. Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat Neurosci 9 (2006) 1134-1141
30. Overstreet D.H., Pucilowski O., Rezvani A.H., and Janowsky D.S. Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. Psychopharmacology (Berl) 121 (1995) 27-37
31. Pucilowski O., Overstreet D.H., Rezvani A.H., and Janowsky D.S. Chronic mild stress-induced anhedonia: greater effect in a genetic rat model of depression. Physiol Behav 54 (1993) 1215-1220
32. Benca R.M., Overstreet D.E., Gilliland M.A., Russell D., Bergmann B.M., and Obermeyer W.H. Increased basal REM sleep but no difference in dark induction or light suppression of REM sleep in flinders rats with cholinergic supersensitivity. Neuropsychopharmacology 15 (1996) 45-51
33. Rosa-Neto P., Diksic M., Okazawa H., Leyton M., Ghadirian N., Mzengeza S., Nakai A., Debonnel G., Blier P., and Benkelfat C. Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression. Arch Gen Psychiatry 61 (2004) 556-563
34. Hasegawa S., Nishi K., Watanabe A., Overstreet D.H., and Diksic M. Brain 5-HT synthesis in the Flinders Sensitive Line rat model of depression: an autoradiographic study. Neurochem Int 48 (2006) 358-366. The authors describe preclinical evidence for an in vivo reduction of brain 5-HT synthesis in FSL rats that were selected by an increased sensitivity to muscarinic cholinergic agonists.
35. Overstreet D.H., Janowsky D.S., Pucilowski O., and Rezvani A.H. Swim test immobility co-segregates with serotonergic but not cholinergic sensitivity in cross-breeds of Flinders Line rats. Psychiatr Genet 4 (1994) 101-107
36. Overstreet D.H. Behavioral characteristics of rat lines selected for differential hypothermic responses to cholinergic or serotonergic agonists. Behav Genet 32 (2002) 335-348
37. Blier P., and Ward N.M. Is there a role for 5-HT1A agonists in the treatment of depression?. Biol Psychiatry 53 (2003) 193-203
38. Stockmeier C.A., Shapiro L.A., Dilley G.E., Kolli T.N., Friedman L., and Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci 18 (1998) 7394-7401
39. Overstreet D.H., Rezvani A.H., Pucilowski O., Gause L., and Janowsky D.S. Rapid selection for serotonin-1A sensitivity in rats. Psychiatr Genet 4 (1994) 57-62
40. Overstreet D.H., Rezvani A.H., Knapp D.J., Crews F.T., and Janowsky D.S. Further selection of rat lines differing in 5-HT-1A receptor sensitivity: behavioral and functional correlates. Psychiatr Genet 6 (1996) 107-117
41. File S.E., Ouagazzal A.M., Gonzalez L.E., and Overstreet D.H. Chronic fluoxetine in tests of anxiety in rat lines selectively bred for differential 5-HT1A receptor function. Pharmacol Biochem Behav 62 (1999) 695-701
42. Commissaris R.L., Ardayfio P.A., McQueen D.A., Gilchrist III G.A., and Overstreet D.H. Conflict behavior and the effects of 8-OHDPAT treatment in rats selectively bred for differential 5-HT(1A)-induced hypothermia. Pharmacol Biochem Behav 67 (2000) 199-205
43. Knapp D.J., Sim-Selley L.J., Breese G.R., and Overstreet D.H. Selective breeding of 5-HT(1A) receptor-mediated responses: application to emotion and receptor action. Pharmacol Biochem Behav 67 (2000) 701-708
44. Lachman H.M., Papolos D.F., Weiner E.D., Ramazankhana R., Hartnick C., Edwards E., and Henn F.A. Hippocampal neuropeptide Y mRNA is reduced in a strain of learned helpless resistant rats. Brain Res Mol Brain Res 14 (1992) 94-100
45. King J.A., and Edwards E. Early stress and genetic influences on hypothalamic-pituitary-adrenal axis functioning in adulthood. Horm Behav 36 (1999) 79-85
46. King J.A., Abend S., and Edwards E. Genetic predisposition and the development of posttraumatic stress disorder in an animal model. Biol Psychiatry 50 (2001) 231-237
47. Neumaier J.F., Edwards E., and Plotsky P.M. 5-HT(1B) mRNA regulation in two animal models of altered stress reactivity. Biol Psychiatry 51 (2002) 902-908
48. Sanchis-Segura C., Spanagel R., Henn F.A., and Vollmayr B. Reduced sensitivity to sucrose in rats bred for helplessness: a study using the matching law. Behav Pharmacol 16 (2005) 267-270
49. Weiss J.M., Cierpial M.A., and West C.H. Selective breeding of rats for high and low motor activity in a swim test: toward a new animal model of depression. Pharmacol Biochem Behav 61 (1998) 49-66
50. West C.H., and Weiss J.M. A selective test for antidepressant treatments using rats bred for stress-induced reduction of motor activity in the swim test. Psychopharmacology (Berl) 182 (2005) 9-23
51. Vaugeois J.M., Passera G., Zuccaro F., and Costentin J. Individual differences in response to imipramine in the mouse tail suspension test. Psychopharmacology (Berl) 134 (1997) 387-391
52. El Yacoubi M., Bouali S., Popa D., Naudon L., Leroux-Nicollet I., Hamon M., Costentin J., Adrien J., and Vaugeois J.M. Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression. Proc Natl Acad Sci USA 100 (2003) 6227-6232
53. Popa D., El Yacoubi M., Vaugeois J.M., Hamon M., and Adrien J. Homeostatic regulation of sleep in a genetic model of depression in the mouse: effects of muscarinic and 5-HT1A receptor activation. Neuropsychopharmacology 31 (2006) 1637-1646
54. Svenningsson P., Chergui K., Rachleff I., Flajolet M., Zhang X., El Yacoubi M., Vaugeois J.M., Nomikos G.G., and Greengard P. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 311 (2006) 77-80. This paper describes extensive evidence for a role of p11 (also named S100A10 or annexin II light chain) in depression by using different approaches, from mouse models to human brain tissue from depressed patients.
55. Kromer S.A., Kessler M.S., Milfay D., Birg I.N., Bunck M., Czibere L., Panhuysen M., Putz B., Deussing J.M., Holsboer F., et al. Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J Neurosci 25 (2005) 4375-4384
56. Yoshikawa T., Watanabe A., Ishitsuka Y., Nakaya A., and Nakatani N. Identification of multiple genetic loci linked to the propensity for "behavioral despair" in mice. Genome Res 12 (2002) 357-366